Supplement to mpox protocol section 3.7: Study flow: data sources and data collection

Overview

WHO has worked with various stakeholders to ascertain core data to be collected during pregnancy, labor and after birth of neonate at health facilities or obstetric and neonatal units, to standardize data collected which is needed to diagnose maternal and neonatal outcomes as per standard definitions (table 1). Definitions and other relevant aspects of data elements measured as the minimum core data set include are included. The WHO mMNHDS are also aligned with the global adverse event reporting system (GAIA) definitions for maternal and neonatal outcomes that include levels of diagnostic certainty and the required data elements that will inform these outcomes (table 2).

 

WHO Team
Pharmacovigilance (PVG)